SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Oragenics Inc. – ‘10-K’ for 12/31/23 – ‘EX-101.SCH’

On:  Friday, 3/29/24, at 4:16pm ET   ·   For:  12/31/23   ·   Accession #:  1493152-24-11979   ·   File #:  1-32188

Previous ‘10-K’:  ‘10-K’ on 4/17/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   31 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/29/24  Oragenics Inc.                    10-K       12/31/23   80:6.5M                                   M2 Compliance LLC/FA

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.33M 
 2: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     72K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     22K 
 4: EX-23.2     Consent of Expert or Counsel                        HTML     21K 
 9: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     37K 
                Awarded Compensation                                             
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
15: R1          Cover                                               HTML    103K 
16: R2          Consolidated Balance Sheets                         HTML    101K 
17: R3          Consolidated Balance Sheets (Parenthetical)         HTML     45K 
18: R4          Consolidated Statements of Operations               HTML     89K 
19: R5          Consolidated Statements of Changes in               HTML     82K 
                Shareholders' Equity                                             
20: R6          Consolidated Statements of Cash Flows               HTML    105K 
21: R7          Pay vs Performance Disclosure                       HTML     34K 
22: R8          Insider Trading Arrangements                        HTML     28K 
23: R9          Basis of Presentation                               HTML     36K 
24: R10         Significant Accounting Policies                     HTML     51K 
25: R11         Acquisition of Concussion Assets                    HTML     32K 
26: R12         Property and Equipment, net                         HTML     34K 
27: R13         Accounts Payable and Accrued Expenses               HTML     29K 
28: R14         Short-Term Notes Payable                            HTML     32K 
29: R15         Prepaid Expense Assets - Current and Long-Term      HTML     30K 
30: R16         Shareholders? Equity                                HTML     65K 
31: R17         Stock Compensation Plan                             HTML     77K 
32: R18         Retirement Plan                                     HTML     29K 
33: R19         Income Taxes                                        HTML     72K 
34: R20         Commitments and Contingencies                       HTML     49K 
35: R21         Subsequent Events                                   HTML     30K 
36: R22         Significant Accounting Policies (Policies)          HTML     91K 
37: R23         Acquisition of Concussion Assets (Tables)           HTML     27K 
38: R24         Property and Equipment, net (Tables)                HTML     31K 
39: R25         Accounts Payable and Accrued Expenses (Tables)      HTML     28K 
40: R26         Short-Term Notes Payable (Tables)                   HTML     31K 
41: R27         Prepaid Expense Assets - Current and Long-Term      HTML     28K 
                (Tables)                                                         
42: R28         Shareholders? Equity (Tables)                       HTML     40K 
43: R29         Stock Compensation Plan (Tables)                    HTML     69K 
44: R30         Income Taxes (Tables)                               HTML     65K 
45: R31         Commitments and Contingencies (Tables)              HTML     45K 
46: R32         Basis of Presentation (Details Narrative)           HTML     48K 
47: R33         Significant Accounting Policies (Details            HTML     31K 
                Narrative)                                                       
48: R34         Schedule of Acquisition of Assets (Details)         HTML     35K 
49: R35         Acquisition of Concussion Assets (Details           HTML     35K 
                Narrative)                                                       
50: R36         Summary of Property and Equipment, Net (Details)    HTML     39K 
51: R37         Property and Equipment, net (Details Narrative)     HTML     28K 
52: R38         Summary of Accounts Payable and Accrued Expenses    HTML     33K 
                (Details)                                                        
53: R39         Summary of Short-Term Notes payable (Details)       HTML     24K 
54: R40         Summary of Short-Term Notes payable (Details)       HTML     32K 
                (Parenthetical)                                                  
55: R41         Schedule of Expense and Other Current Assets        HTML     34K 
                (Details)                                                        
56: R42         Schedule of Warrants Outstanding and Exercisable    HTML     46K 
                (Details)                                                        
57: R43         Shareholders? Equity (Details Narrative)            HTML     72K 
58: R44         Summary of Assumptions Used to Estimate the Fair    HTML     40K 
                Value of Stock Options Granted (Details)                         
59: R45         Summary of Stock Option Activity (Details)          HTML     58K 
60: R46         Summary of Weighted Average Grant Fair Value of     HTML     28K 
                Stock Options (Details)                                          
61: R47         Schedule of Restricted Stock Activity (Details)     HTML     42K 
62: R48         Stock Compensation Plan (Details Narrative)         HTML     49K 
63: R49         Retirement Plan (Details Narrative)                 HTML     25K 
64: R50         Schedule of Components of Provision for Income      HTML     34K 
                Taxes (Details)                                                  
65: R51         Summary of Components of Deferred Tax (Details)     HTML     39K 
66: R52         Schedule of Reconciliation of Tax Computed at       HTML     39K 
                Statutory Federal Rate (Details)                                 
67: R53         Schedule of Reconciliation of Tax Computed at       HTML     24K 
                Statutory Federal Rate (Details) (Parenthetical)                 
68: R54         Schedule of Reconciliation of Unrecognized Tax      HTML     31K 
                Benefits (Details)                                               
69: R55         Income Taxes (Details Narrative)                    HTML     37K 
70: R56         Schedule of Supplemental Balance Sheet Information  HTML     26K 
                Related to Leases (Details)                                      
71: R57         Schedule of Operating lease liabilities (Details)   HTML     29K 
72: R58         Schedule of Cost Component of Operating Leases      HTML     28K 
                (Details)                                                        
73: R59         Schedule of Supplemental Cash Flow Information      HTML     24K 
                Related to Operating Leases (Details)                            
74: R60         Commitments and Contingencies (Details Narrative)   HTML     51K 
75: R61         Subsequent Events (Details Narrative)               HTML     31K 
77: XML         IDEA XML File -- Filing Summary                      XML    135K 
80: XML         XBRL Instance -- form10-k_htm                        XML    839K 
76: EXCEL       IDEA Workbook of Financial Report Info              XLSX    111K 
11: EX-101.CAL  XBRL Calculations -- ogen-20231231_cal               XML    163K 
12: EX-101.DEF  XBRL Definitions -- ogen-20231231_def                XML    329K 
13: EX-101.LAB  XBRL Labels -- ogen-20231231_lab                     XML    942K 
14: EX-101.PRE  XBRL Presentations -- ogen-20231231_pre              XML    722K 
10: EX-101.SCH  XBRL Schema -- ogen-20231231                         XSD    124K 
78: JSON        XBRL Instance as JSON Data -- MetaLinks              404±   569K 
79: ZIP         XBRL Zipped Folder -- 0001493152-24-011979-xbrl      Zip    459K

‘EX-101.SCH’   —   XBRL Schema — ogen-20231231

This Exhibit is an XBRL File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaiMabP9z5Z8OekhvWB1bUn6zyQl0fmujSFsosWm4QAH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:OGEN="http://oragenics.com/20231231" elementFormDefault="qualified" targetNamespace="http://oragenics.com/20231231">
<annotation>
<appinfo>
<link:roleType roleURI="http://oragenics.com/role/Cover" id="Cover">
<link:definition> 00000001 - Document - Cover </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/BalanceSheets" id="BalanceSheets">
<link:definition> 00000002 - Statement - Consolidated Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
<link:definition> 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/StatementsOfOperations" id="StatementsOfOperations">
<link:definition> 00000004 - Statement - Consolidated Statements of Operations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/StatementsOfChangesInShareholdersEquity" id="StatementsOfChangesInShareholdersEquity">
<link:definition> 00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
<link:definition> 00000006 - Statement - Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/BasisOfPresentation" id="BasisOfPresentation">
<link:definition> 995512 - Disclosure - Basis of Presentation </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
<link:definition> 995513 - Disclosure - Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/AcquisitionOfConcussionAssets" id="AcquisitionOfConcussionAssets">
<link:definition> 995514 - Disclosure - Acquisition of Concussion Assets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
<link:definition> 995515 - Disclosure - Property and Equipment, net </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/AccountsPayableAndAccruedExpenses" id="AccountsPayableAndAccruedExpenses">
<link:definition> 995516 - Disclosure - Accounts Payable and Accrued Expenses </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/Short-termNotesPayable" id="Short-termNotesPayable">
<link:definition> 995517 - Disclosure - Short-Term Notes Payable </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/PrepaidExpenseAssetsCurrentAndLong-term" id="PrepaidExpenseAssetsCurrentAndLong-term">
<link:definition> 995518 - Disclosure - Prepaid Expense Assets – Current and Long-Term </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ShareholdersEquity" id="ShareholdersEquity">
<link:definition> 995519 - Disclosure - Shareholders’ Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/StockCompensationPlan" id="StockCompensationPlan">
<link:definition> 995520 - Disclosure - Stock Compensation Plan </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/RetirementPlan" id="RetirementPlan">
<link:definition> 995521 - Disclosure - Retirement Plan </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition> 995522 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 995523 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition> 995524 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
<link:definition> 995525 - Disclosure - Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/AcquisitionOfConcussionAssetsTables" id="AcquisitionOfConcussionAssetsTables">
<link:definition> 995526 - Disclosure - Acquisition of Concussion Assets (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
<link:definition> 995527 - Disclosure - Property and Equipment, net (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/AccountsPayableAndAccruedExpensesTables" id="AccountsPayableAndAccruedExpensesTables">
<link:definition> 995528 - Disclosure - Accounts Payable and Accrued Expenses (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/Short-termNotesPayableTables" id="Short-termNotesPayableTables">
<link:definition> 995529 - Disclosure - Short-Term Notes Payable (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/PrepaidExpenseAssetsCurrentAndLong-termTables" id="PrepaidExpenseAssetsCurrentAndLong-termTables">
<link:definition> 995530 - Disclosure - Prepaid Expense Assets – Current and Long-Term (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ShareholdersEquityTables" id="ShareholdersEquityTables">
<link:definition> 995531 - Disclosure - Shareholders’ Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/StockCompensationPlanTables" id="StockCompensationPlanTables">
<link:definition> 995532 - Disclosure - Stock Compensation Plan (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition> 995533 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
<link:definition> 995534 - Disclosure - Commitments and Contingencies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/BasisOfPresentationDetailsNarrative" id="BasisOfPresentationDetailsNarrative">
<link:definition> 995535 - Disclosure - Basis of Presentation (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SignificantAccountingPoliciesDetailsNarrative" id="SignificantAccountingPoliciesDetailsNarrative">
<link:definition> 995536 - Disclosure - Significant Accounting Policies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfAcquisitionOfAssetsDetails" id="ScheduleOfAcquisitionOfAssetsDetails">
<link:definition> 995537 - Disclosure - Schedule of Acquisition of Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/AcquisitionOfConcussionAssetsDetailsNarrative" id="AcquisitionOfConcussionAssetsDetailsNarrative">
<link:definition> 995538 - Disclosure - Acquisition of Concussion Assets (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SummaryOfPropertyAndEquipmentNetDetails" id="SummaryOfPropertyAndEquipmentNetDetails">
<link:definition> 995539 - Disclosure - Summary of Property and Equipment, Net (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/PropertyAndEquipmentNetDetailsNarrative" id="PropertyAndEquipmentNetDetailsNarrative">
<link:definition> 995540 - Disclosure - Property and Equipment, net (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SummaryOfAccountsPayableAndAccruedExpensesDetails" id="SummaryOfAccountsPayableAndAccruedExpensesDetails">
<link:definition> 995541 - Disclosure - Summary of Accounts Payable and Accrued Expenses (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SummaryOfShort-termNotesPayableDetails" id="SummaryOfShort-termNotesPayableDetails">
<link:definition> 995542 - Disclosure - Summary of Short-Term Notes payable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SummaryOfShort-termNotesPayableDetailsParenthetical" id="SummaryOfShort-termNotesPayableDetailsParenthetical">
<link:definition> 995543 - Disclosure - Summary of Short-Term Notes payable (Details) (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfExpenseAndOtherCurrentAssetsDetails" id="ScheduleOfExpenseAndOtherCurrentAssetsDetails">
<link:definition> 995544 - Disclosure - Schedule of Expense and Other Current Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" id="ScheduleOfWarrantsOutstandingAndExercisableDetails">
<link:definition> 995545 - Disclosure - Schedule of Warrants Outstanding and Exercisable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ShareholdersEquityDetailsNarrative" id="ShareholdersEquityDetailsNarrative">
<link:definition> 995546 - Disclosure - Shareholders’ Equity (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SummaryOfAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedDetails" id="SummaryOfAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedDetails">
<link:definition> 995547 - Disclosure - Summary of Assumptions Used to Estimate the Fair Value of Stock Options Granted (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SummaryOfStockOptionActivityDetails" id="SummaryOfStockOptionActivityDetails">
<link:definition> 995548 - Disclosure - Summary of Stock Option Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SummaryOfWeightedAverageGrantFairValueOfStockOptionsDetails" id="SummaryOfWeightedAverageGrantFairValueOfStockOptionsDetails">
<link:definition> 995549 - Disclosure - Summary of Weighted Average Grant Fair Value of Stock Options (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfRestrictedStockActivityDetails" id="ScheduleOfRestrictedStockActivityDetails">
<link:definition> 995550 - Disclosure - Schedule of Restricted Stock Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/StockCompensationPlanDetailsNarrative" id="StockCompensationPlanDetailsNarrative">
<link:definition> 995551 - Disclosure - Stock Compensation Plan (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/RetirementPlanDetailsNarrative" id="RetirementPlanDetailsNarrative">
<link:definition> 995552 - Disclosure - Retirement Plan (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails" id="ScheduleOfComponentsOfProvisionForIncomeTaxesDetails">
<link:definition> 995553 - Disclosure - Schedule of Components of Provision for Income Taxes (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SummaryOfComponentsOfDeferredTaxDetails" id="SummaryOfComponentsOfDeferredTaxDetails">
<link:definition> 995554 - Disclosure - Summary of Components of Deferred Tax (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfReconciliationOfTaxComputedAtStatutoryFederalRateDetails" id="ScheduleOfReconciliationOfTaxComputedAtStatutoryFederalRateDetails">
<link:definition> 995555 - Disclosure - Schedule of Reconciliation of Tax Computed at Statutory Federal Rate (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfReconciliationOfTaxComputedAtStatutoryFederalRateDetailsParenthetical" id="ScheduleOfReconciliationOfTaxComputedAtStatutoryFederalRateDetailsParenthetical">
<link:definition> 995556 - Disclosure - Schedule of Reconciliation of Tax Computed at Statutory Federal Rate (Details) (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails" id="ScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails">
<link:definition> 995557 - Disclosure - Schedule of Reconciliation of Unrecognized Tax Benefits (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
<link:definition> 995558 - Disclosure - Income Taxes (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" id="ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails">
<link:definition> 995559 - Disclosure - Schedule of Supplemental Balance Sheet Information Related to Leases (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" id="ScheduleOfOperatingLeaseLiabilitiesDetails">
<link:definition> 995560 - Disclosure - Schedule of Operating lease liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfCostComponentOfOperatingLeasesDetails" id="ScheduleOfCostComponentOfOperatingLeasesDetails">
<link:definition> 995561 - Disclosure - Schedule of Cost Component of Operating Leases (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" id="ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails">
<link:definition> 995562 - Disclosure - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
<link:definition> 995563 - Disclosure - Commitments and Contingencies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://oragenics.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
<link:definition> 995564 - Disclosure - Subsequent Events (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="ogen-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="ogen-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="ogen-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="ogen-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
<import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
<import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
<import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
<element id="OGEN_OdysseyHealthIncMember" name="OdysseyHealthIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_OfficeandComputerEquipmentMember" name="OfficeandComputerEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_DirectorsAndOfficersLiabilityMember" name="DirectorsAndOfficersLiabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_OfficersMember" name="OfficersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_AssetPurchaseAgreementMember" name="AssetPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_RangeOneMember" name="RangeOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_RangeTwoMember" name="RangeTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_RangeThreeMember" name="RangeThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_RangeFourMember" name="RangeFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_RangeFiveMember" name="RangeFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_RangeSixMember" name="RangeSixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_TwoThousandTwentyOneEquityIncentivePlanMember" name="TwoThousandTwentyOneEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_ResearchandDevelopmentMember" name="ResearchandDevelopmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_AlachuaFacilityMember" name="AlachuaFacilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_TampaFacilityMember" name="TampaFacilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_PrepaidResearchAndDevelopmentExpense" name="PrepaidResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_StockIssuedDuringPeriodValueConversionOfSeriesFPreferredStockToCommonStock" name="StockIssuedDuringPeriodValueConversionOfSeriesFPreferredStockToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_StockIssuedDuringPeriodSharesConversionOfSeriesFPreferredStockToCommonStock" name="StockIssuedDuringPeriodSharesConversionOfSeriesFPreferredStockToCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_StockIssuedDuringPeriodValueConversionOfSeriesBPreferredStockToCommonStock" name="StockIssuedDuringPeriodValueConversionOfSeriesBPreferredStockToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_StockIssuedDuringPeriodSharesConversionOfSeriesBPreferredStockToCommonStock" name="StockIssuedDuringPeriodSharesConversionOfSeriesBPreferredStockToCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_StockIssuedDuringPeriodValueProceedsFromIssuanceForCommonStock" name="StockIssuedDuringPeriodValueProceedsFromIssuanceForCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_StockIssuedDuringPeriodSharesProceedsFromIssuanceForCommonStock" name="StockIssuedDuringPeriodSharesProceedsFromIssuanceForCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_WriteOffOfInProcessResearchAndDevelopment" name="WriteOffOfInProcessResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_IncreaseDecreaseInPrepaidResearchAndDevelopment" name="IncreaseDecreaseInPrepaidResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_IssuanceOfSeriesFPreferredStockForInprocessResearchAndDevelopment" name="IssuanceOfSeriesFPreferredStockForInprocessResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_ConversionOfStockAmountConverted" name="ConversionOfStockAmountConverted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_ConversionOfStockAmountIssued" name="ConversionOfStockAmountIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_DisclosurePrepaidExpenseAssetsCurrentAndLongtermAbstract" name="DisclosurePrepaidExpenseAssetsCurrentAndLongtermAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_PrepaidExpenseAssetsDisclosureTextBlock" name="PrepaidExpenseAssetsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_ScheduleOfPrepaidExpenseAndOtherCurrentAssetsTableTextBlock" name="ScheduleOfPrepaidExpenseAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock" name="ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" name="ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_NetProceedsFromIssuanceOrSaleOfEquity" name="NetProceedsFromIssuanceOrSaleOfEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_CurrentAndLongTermPrepaidAssets" name="CurrentAndLongTermPrepaidAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_ClassOfWarrantOrRightOutstandingExercisable" name="ClassOfWarrantOrRightOutstandingExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisable" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_PrepaidExpenseAndOtherCurrentAssetsDisclosureTextBlock" name="PrepaidExpenseAndOtherCurrentAssetsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_SecurityPurchaseAgreementMember" name="SecurityPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_CommonStocksSharesOutstanding" name="CommonStocksSharesOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_RangeSevenMember" name="RangeSevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_UnrecognizedTaxBenefitsIncreasesForReturnToProvisionTrueUp" name="UnrecognizedTaxBenefitsIncreasesForReturnToProvisionTrueUp" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_GainLossOnDisposalOfFixedAssets" name="GainLossOnDisposalOfFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_UnderwritingAgreementMember" name="UnderwritingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_BusinessCombinationConsiderationTransferred" name="BusinessCombinationConsiderationTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="OGEN_ThirdPartyVendorMember" name="ThirdPartyVendorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
</schema>

31 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/29/23  Oragenics Inc.                    8-K:2,5,9  12/28/23   11:384K                                   M2 Compliance LLC/FA
12/15/23  Oragenics Inc.                    8-K:3,5,9  12/14/23   13:517K                                   M2 Compliance LLC/FA
12/08/23  Oragenics Inc.                    8-K:5,9    12/04/23   11:335K                                   M2 Compliance LLC/FA
 3/08/23  Oragenics Inc.                    8-K:5,9     3/07/23   12:391K                                   M2 Compliance LLC/FA
 1/23/23  Oragenics Inc.                    8-K:3,5,9   1/20/23   12:2.5M                                   M2 Compliance LLC/FA
 6/23/22  Oragenics Inc.                    8-K:5,9     6/23/22   12:417K                                   M2 Compliance LLC/FA
 3/24/22  Oragenics Inc.                    10-K       12/31/21   77:7M                                     M2 Compliance LLC/FA
 2/28/22  Oragenics Inc.                    8-K:3,5,9   2/25/22   16:777K                                   M2 Compliance LLC/FA
11/15/21  Oragenics Inc.                    10-Q        9/30/21   49:3.7M                                   M2 Compliance LLC/FA
 8/14/20  Oragenics Inc.                    10-Q        6/30/20   54:3M                                     M2 Compliance LLC/FA
 5/04/20  Oragenics Inc.                    8-K:1,2,3,5 5/01/20    5:676K                                   M2 Compliance LLC/FA
 3/04/20  Oragenics Inc.                    10-K       12/31/19   75:5.4M                                   M2 Compliance LLC/FA
 6/21/19  Oragenics Inc.                    8-K:5,9     6/20/19    2:39K                                    Donnelley … Solutions/FA
 7/17/18  Oragenics Inc.                    8-K:1,5,8,9 7/13/18    6:485K                                   Donnelley … Solutions/FA
 7/09/18  Oragenics Inc.                    S-1/A       7/06/18    6:1M                                     Donnelley … Solutions/FA
 6/26/18  Oragenics Inc.                    8-K:5,9     6/22/18    3:47K                                    Donnelley … Solutions/FA
 4/10/18  Oragenics Inc.                    8-K:1,3,9   4/06/18    6:386K                                   Donnelley … Solutions/FA
 1/19/18  Oragenics Inc.                    8-K:3,5,9   1/19/18    2:28K                                    Donnelley … Solutions/FA
12/29/17  Oragenics Inc.                    8-K:5,8,9  12/29/17    4:212K                                   Donnelley … Solutions/FA
11/09/17  Oragenics Inc.                    8-K:1,3,5,811/08/17   13:688K                                   Donnelley … Solutions/FA
 8/01/17  Oragenics Inc.                    8-K:1,3,9   7/27/17    3:209K                                   Donnelley … Solutions/FA
 5/05/17  Oragenics Inc.                    8-K:5,9     5/04/17    2:31K                                    Donnelley … Solutions/FA
 3/18/15  Oragenics Inc.                    8-K:5,9     3/16/15    4:109K                                   Donnelley … Solutions/FA
 8/07/14  Oragenics Inc.                    10-Q        6/30/14   46:2.2M                                   Donnelley … Solutions/FA
 3/26/13  Oragenics Inc.                    10-K       12/31/12   74:5.9M                                   Donnelley … Solutions/FA
10/25/12  Oragenics Inc.                    8-K:5,9    10/23/12    2:134K                                   Donnelley … Solutions/FA
 4/16/12  Oragenics Inc.                    10-K       12/31/11   39:3M                                     Donnelley … Solutions/FA
11/14/11  Oragenics Inc.                    10-Q        9/30/11   28:1M                                     Donnelley … Solutions/FA
 8/24/10  Oragenics Inc.                    8-K:5,9     8/20/10    2:19K                                    Donnelley … Solutions/FA
 6/09/10  Oragenics Inc.                    8-K:5,9     6/04/10    3:79K                                    Toppan Merrill/FA
10/16/02  Oragenics Inc.                    SB-2                  45:1.3M                                   Law Office of Con… PS/FA
↑Top
Filing Submission 0001493152-24-011979   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 16, 5:16:46.3pm ET